Overview

Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

Phase 1 study in HVC (Hepatitis C Virus) infected subjects to determine pharmacokinetics, safety and efficacy in subjects with no or inadequate response to prior treatment.

Phase:

Phase 1

Details

Lead Sponsor:

Pfizer

Treatments:

Antiviral Agents